McMullen Michael R. bought BMY
March 31, 2026 · Form 4 insider transaction
McMullen Michael R. bought 577.082 shares of Bristol-Myers Squibb Company at $60.65 per share, a transaction worth $35.0K. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
577.082
Price
$60.65
Total value
$35.0K
InsiderMcMullen Michael R.
Role—
SecurityDeferred Share Units
Transaction codeA: Grant or award
Transaction dateMarch 31, 2026
Filing dateApril 2, 2026
Shares owned after15,557
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each Deferred Share Unit will be converted into a share of common stock upon settlement. The Deferred Share Units become settleable when the reporting person ceases to be a director or at a future date previously specified by the reporting person.; Includes deferred compensation and dividends reinvested under the 1987 Deferred Compensation Plan for Non-Employee Directors.